ROIVANT SCIENCES LTD. 26,666,666 Common Shares (par value $0.0000000341740141 per share) Underwriting AgreementUnderwriting Agreement • February 7th, 2023 • Roivant Sciences Ltd. • Pharmaceutical preparations • New York
Roivant Sciences Ltd., a Bermuda exempted limited company (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 26,666,666 of its common shares, par value $0.0000000341740141 per share (the “Shares”). The 26,666,666 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 3,999,999 Shares as provided in Section 2. The additional 3,999,999 Shares to be sold by the Company pursuant to such option are called the “Option Shares.” The Firm Shares and, if and to the extent such option is exercised, the Option Shares, are collectively called the “Offered Shares.” Goldman Sachs & Co. LLC, SVB Securities LLC, Cowen and Company, LLC and Cantor Fitzgerald & Co. have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Offer
